Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending March 2015. The report serves as a notification regarding the publication of the 2015 Notice of Annual General Meeting (AGM).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
The filing announces that the 2015 AGM will be held on Thursday, May 7, 2015, at 2:30 pm at The Queen Elizabeth II Conference Centre in London. The 2015 AGM Notice, 2015 Annual Report, and 2015 Annual Summary have been published on the company website and distributed to shareholders electing paper communications. The notice has been submitted to the UK Listing Authority in compliance with Listing Rule 9.6.1.
Investor Verification Checklist
- Verify the date and location of the 2015 Annual General Meeting (May 7, 2015, London).
- Confirm the availability of the 2015 Annual Report and Annual Summary on the GSK investor website.
- Check the UK Listing Authority website (Morningstar) for the official inspection of the AGM Notice.
- Note that this filing contains no financial results; refer to the 2015 Annual Report for financial metrics.